| Clioquinol | Approved Vet Approved Withdrawn | EGLN1 | 54583 |
downregulated | Clioquinol results in decreased expression of EGLN1 mRNA | 1q42.2 | |
| Clioquinol | Approved Vet Approved Withdrawn | EGLN2 | 112398 |
downregulated | Clioquinol results in decreased expression of EGLN2 mRNA | 19q13.2 | |
| Clioquinol | Approved Vet Approved Withdrawn | EGR1 | 1958 |
upregulated | Clioquinol results in increased expression of EGR1 mRNA | 5q31.2 | |
| Clioquinol | Approved Vet Approved Withdrawn | EPO | 2056 |
downregulated | Clioquinol results in decreased expression of EPO mRNA | 7q22.1 | |
| Clioquinol | Approved Vet Approved Withdrawn | EPO | 2056 |
upregulated | Clioquinol results in increased expression of EPO mRNA | 7q22.1 | |
| Clioquinol | Approved Vet Approved Withdrawn | GADD45A | 1647 |
upregulated | Clioquinol results in increased expression of GADD45A mRNA | 1p31.3 | |
| Clioquinol | Approved Vet Approved Withdrawn | HIF3A | 64344 |
downregulated | Clioquinol results in decreased expression of HIF3A mRNA | 19q13.32 | |
| Clioquinol | Approved Vet Approved Withdrawn | MIF | 4282 |
upregulated | Clioquinol results in increased expression of MIF mRNA | 22q11.23 | |
| Clioquinol | Approved Vet Approved Withdrawn | P4HA2 | 8974 |
downregulated | Clioquinol results in decreased expression of P4HA2 mRNA | 5q31.1 | |
| Clioquinol | Approved Vet Approved Withdrawn | PGK1 | 5230 |
upregulated | Clioquinol results in increased expression of PGK1 mRNA | Xq21.1 | |
| Clioquinol | Approved Vet Approved Withdrawn | VEGFA | 7422 |
downregulated | Clioquinol results in decreased expression of VEGFA mRNA | 6p21.1 | |
| Clioquinol | Approved Vet Approved Withdrawn | VEGFA | 7422 |
upregulated | Clioquinol results in increased expression of VEGFA mRNA | 6p21.1 | |
| Clobetasol | Approved Investigational Withdrawn | ABCC1 | 4363 |
downregulated | Clobetasol results in decreased expression of ABCC1 mRNA | 16p13.11 | |
| Clobetasol | Approved Investigational Withdrawn | CYP1A1 | 1543 |
upregulated | Clobetasol results in increased expression of CYP1A1 mRNA | 15q24.1 | |
| Clobetasol | Approved Investigational Withdrawn | CYP3A4 | 1576 |
upregulated | [Clobetasol results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Clobetasol | Approved Investigational Withdrawn | CYP3A5 | 1577 |
upregulated | Clobetasol results in increased expression of CYP3A5 mRNA | 7q22.1 | |
| Clobetasol | Approved Investigational Withdrawn | GCLC | 2729 |
downregulated | Clobetasol results in decreased expression of GCLC mRNA | 6p12.1 | |
| Clofibrate | Approved Withdrawn | ABCA1 | 19 |
upregulated | Clofibrate results in increased expression of ABCA1 mRNA | 9q31.1 | |
| Clofibrate | Approved Withdrawn | CCND2 | 894 |
downregulated | Clofibrate results in decreased expression of CCND2 mRNA | 12p13.32 | |
| Clofibrate | Approved Withdrawn | CPT1A | 1374 |
upregulated | Clofibrate results in increased expression of CPT1A mRNA | 11q13.3 | |
| Clofibrate | Approved Withdrawn | CYP1A1 | 1543 |
upregulated | Clofibrate results in increased expression of CYP1A1 mRNA | 15q24.1 | |
| Clofibrate | Approved Withdrawn | CYP4A11 | 1579 |
upregulated | Clofibrate results in increased expression of CYP4A11 mRNA | 1p33 | |
| Clofibrate | Approved Withdrawn | MTTP | 4547 |
downregulated | Clofibrate results in decreased expression of MTTP mRNA | 4q23 | |
| Clofibrate | Approved Withdrawn | MYB | 4602 |
downregulated | Clofibrate results in decreased expression of MYB mRNA | 6q23.3 | |
| Clofibrate | Approved Withdrawn | PPARA | 5465 |
upregulated | Clofibrate results in increased expression of PPARA mRNA | 22q13.31 | |